Revenue
No reported data
Vor Biopharma Inc. (VOR)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Research & development | $321.5M | $93.3M | $94.3M | $64.5M | $47.5M | $31.6M |
| Operating expenses | $371.6M | $121.2M | $126.0M | $93.4M | $69.0M | $43.4M |
| Operating income | −$371.6M | −$121.2M | −$126.0M | −$93.4M | −$69.0M | −$43.4M |
| Net income | −$696.0M | −$116.9M | −$117.9M | −$92.1M | −$68.9M | −$43.3M |
| Basic EPSper diluted share | -$70.50 | -$34.03 | -$1.75 | -$2.33 | -$2.10 | -$230.57 |
| Diluted EPSper diluted share | -$70.50 | -$34.03 | -$1.75 | -$2.33 | -$2.10 | -$230.57 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 22, 2026Form 4 | Shah Rajeev M. +3Director,TenPercentOwner | SellCommon Stock · indirect | 165.2K | $15.77 | $2.60M | 2.40M |
| Apr 20, 2026Form 4 | RA CAPITAL MANAGEMENT, L.P. +3Director,TenPercentOwner | SellCommon Stock · indirect | 172.0K | $15.77 | $2.71M | 2.57M |
| Apr 17, 2026Form 4 | RA CAPITAL MANAGEMENT, L.P. +3Director,TenPercentOwner | SellCommon Stock · indirect | 458.4K | $16.28 | $7.46M | 2.74M |
| Apr 15, 2026Form 4 | RA CAPITAL MANAGEMENT, L.P. +3Director,TenPercentOwner | SellCommon Stock · indirect | 53.6K | $16.01 | $858.8K | 3.20M |
| Apr 14, 2026Form 4 | RA CAPITAL MANAGEMENT, L.P. +3Director,TenPercentOwner | SellCommon Stock · indirect | 153.7K | $15.97 | $2.46M | 3.25M |